Zobrazeno 1 - 10
of 260
pro vyhledávání: '"immune “cold” tumor"'
Autor:
Li X; Cancer Center, the First Hospital of Jilin University, Changchun, Jilin 130021, China., Li Y; Cancer Center, the First Hospital of Jilin University, Changchun, Jilin 130021, China., Tuerxun H; Cancer Center, the First Hospital of Jilin University, Changchun, Jilin 130021, China., Zhao Y; Cancer Center, the First Hospital of Jilin University, Changchun, Jilin 130021, China., Liu X; Cancer Center, the First Hospital of Jilin University, Changchun, Jilin 130021, China., Zhao Y; Cancer Center, the First Hospital of Jilin University, Changchun, Jilin 130021, China. Electronic address: zhaoyuguang@jlu.edu.cn.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Oct; Vol. 179, pp. 117298. Date of Electronic Publication: 2024 Aug 15.
Publikováno v:
Сибирский научный медицинский журнал, Vol 44, Iss 5, Pp 129-137 (2024)
The contribution of immunoregulatory cytokines to the formation of cold airway hyperresponsiveness in asthma patients is important for understanding approaches to therapy. Aim of the study was to investigate the interaction of tumor necrosis factor-a
Externí odkaz:
https://doaj.org/article/f3d17c1aa41548949b2a6fd1d0fbeb73
Autor:
Hansen SB; Department of Biosciences, University of Oslo, Oslo, Norway., Unal B; Department of Biosciences, University of Oslo, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Kuzu OF; Department of Biosciences, University of Oslo, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Saatcioglu F; Department of Biosciences, University of Oslo, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Theranostics [Theranostics] 2024 Oct 21; Vol. 14 (18), pp. 6913-6934. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).
Autor:
Shi W; Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Liu N; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Liu Z; Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Yang Y; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China., Zeng Q; Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Wang Y; Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Song L; Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Hu F; Hangzhou Converd Inc., Hangzhou, Zhejiang 311121, China., Fu J; Hangzhou Converd Inc., Hangzhou, Zhejiang 311121, China., Chen J; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Wu M; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Zhou L; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China., Zhu F; Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200052, China., Gong L; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China., Zhu J; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China., Jiang L; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. Electronic address: jiang_long@shsmu.edu.cn., Lu H; Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic address: roadeer@sjtu.edu.cn.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 May 21; Vol. 5 (5), pp. 101531. Date of Electronic Publication: 2024 May 01.
Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics
Publikováno v:
Heliyon, Vol 10, Iss 18, Pp e37374- (2024)
Background: Glioblastoma (GBM) is a very common primary malignant tumor of the central nervous system (CNS). Aging, macrophage, autophagy, and methylation related genes are hypothesized to be crucial to its pathogenesis. In this study, we aimed to ex
Externí odkaz:
https://doaj.org/article/ad6635d748ec475092f98efb32853625
Autor:
Zhang G; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Li J; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Li G; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Zhang J; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Yang Z; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Yang L; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Jiang S; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China., Wang J; Department of Hepatobiliary Vascular Surgery, Chengdu Seventh People's Hospital, Chengdu, 610041, Sichuan, China. 472142989@qq.com.
Publikováno v:
Clinical and experimental medicine [Clin Exp Med] 2024 Aug 14; Vol. 24 (1), pp. 193. Date of Electronic Publication: 2024 Aug 14.
Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics
Autor:
Zhang, Le a, c, 1, Yan, Xiaoling d, 1, Wang, Yahong e, 1, Wang, Qin a, c, ⁎⁎⁎, Yan, Hua a, f, ⁎⁎, Yan, Yan a, b, c, ⁎
Publikováno v:
In Heliyon 30 September 2024 10(18)
Autor:
Bonnet, Baptiste, Tournier, Louis, Deschamps, Frédéric, Yevich, Steven, Marabelle, Aurélien, Robert, Caroline, Albiges, Laurence, Besse, Benjamin, Bonnet, Victoire, De Baère, Thierry, Tselikas, Lambros
Publikováno v:
Cancers; Mar2024, Vol. 16 Issue 5, p855, 15p
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/43da582f92c44426970f44f2920f8401
Autor:
Khosravi GR; Department of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Mostafavi S; Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Bastan S; Department of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Ebrahimi N; Department of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Gharibvand RS; Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Eskandari N; Department of Medical Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Publikováno v:
Cancer communications (London, England) [Cancer Commun (Lond)] 2024 May; Vol. 44 (5), pp. 521-553. Date of Electronic Publication: 2024 Mar 29.